series-c-plus
Stage
2019
Founded
3
Investors
About
Kriya Therapeutics is a biopharmaceutical company developing gene therapies that target validated biological pathways to treat common diseases in ophthalmology, metabolic disease, and neurology affecting millions globally.
Explore Kriya Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.